# Viselio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/viselio

- Industry: Healthcare
- Headquarters: Bern, Switzerland
- Website: www.viselio.com
- Total disclosed funding: $3.1M
- Latest round: Series A (Feb 28, 2020)
- Investors on record: 2

## About

Based in Bern, Switzerland, and founded in 2016, Viselio AG is a startup company that operates as a provider of Covid-19 testing solutions. The company initially operated as an automated visa service provider platform, that assisted travelers in obtaining visas and other necessary documents digitally, in a fast and cost-effective manner. In February 2022, CIBTvisas, Inc., a portfolio company of Kohlberg & Company, acquired the firm’s software platform (travel visa platform) and its proprietary technology. As of March 2022, the company is being led by its founder and CEO, Niklas Zeller.

Viselio AG primarily offers Covid-19 testing services such as rapid PCR (polymerase chain reaction) and antigen tests in 2 locations including Bern and Zurich. The company also offers group testing, and on-demand on-site testing services, and issues a Swiss Covid certificate or equivalent EU Green pass, that allow travelers and other individuals to comply with the safety standards issued by various organizations worldwide.

## Funding rounds

- Series A, Feb 28, 2020, $3.1M — HOWZAT Partners, EquityPitcher Ventures

## Investors

- HOWZAT Partners (https://capitalatlas.ai/funds/howzat-partners) — Series A
- EquityPitcher Ventures (https://capitalatlas.ai/funds/equitypitcher-ventures) — Series A